Literature DB >> 17237241

Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients.

Caroline Schmidt-Lucke1, Alexandra Aicher, Paola Romagnani, Björn Gareis, Sergio Romagnani, Andreas M Zeiher, Stefanie Dimmeler.   

Abstract

Regulatory T cells (T(reg)) migrate into allografts and induce tolerance of the graft. Immunosuppressive T(reg) are found among CD4+CD25++ T cells and specifically express the forkhead/winged transcription factor FOXP3. We hypothesized that activated T cells and T(reg) might modulate the ongoing inflammation of the cardiac allograft (CA) and that the chronic inflammatory environment might influence the balance between these distinct cell types. We therefore quantified levels of activated T cells and CD4+CD25++ T(reg) in the cardiac and systemic circulation in heart transplant recipients. To determine the influence of the allograft passage on these cells, transcardiac gradients were evaluated in CA recipients (n = 22) compared with controls (n = 18). Systemic levels of circulating T(reg) were significantly lower in CA recipients (8.9 +/- 1.3 microl) compared with controls (15.8 +/- 1.6 microl; P = 0.002). Similarly, the proportion of T(reg) related to the total leukocyte number was significantly lower in CA recipients (P < 0.01). In contrast, systemic levels of circulating activated CD4+ T cells and of circulating plasmacytoid dendritic cells were similar in both groups. In transplant patients, numbers of T(reg) significantly decreased during transcardiac passage (3.0 +/- 0.3 to 2.4 +/- 0.3% of CD4+ T cells, P < 0.01), and FOXP3+ T cells invaded into the allograft. In contrast, numbers of activated CD4+ T cells increased during passage through the allograft, even in the presence of effective immunosuppression. In conclusion, numbers of circulating immunosuppressive T(reg) are reduced in transplant recipients. Recruitment of T(reg) into the cardiac allograft during transcoronary passage may induce graft tolerance during subclinical inflammation potentially influencing allograft vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237241     DOI: 10.1152/ajpheart.01197.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  Reduced levels of both circulating CD4+ CD25+ CD127(low/neg) and CD4+ CD8(neg) invariant natural killer regulatory T cells in stable heart transplant recipients.

Authors:  M Chen; M Mohtize; M-F Matteï; J-P Villemot; C Kohler; G C Faure; M C Béné; M de Carvalho Bittencourt
Journal:  Clin Exp Immunol       Date:  2010-10-29       Impact factor: 4.330

Review 2.  T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival.

Authors:  Mohammad A Khan; Sana Moeez; Suhail Akhtar
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

Review 3.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

4.  Peripheral blood T regulatory cell counts may not predict transplant rejection.

Authors:  Yuchuan Huang; Juan Shan; Chuntao Zhang; Jie Zhang; Li Feng; Shengfu Li; Youping Li
Journal:  BMC Immunol       Date:  2010-07-15       Impact factor: 3.615

5.  Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy.

Authors:  Caroline Schmidt-Lucke; Felicitas Escher; Sophie Van Linthout; Uwe Kühl; Kapka Miteva; Jochen Ringe; Thomas Zobel; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Mediators Inflamm       Date:  2015-02-28       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.